🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Swiss Atrial Fibrillation Pulmonary Vein Isolation Registry

Recruitingn/aAges 18 Years - anyAllUniversity Hospital, Basel, Switzerland
NCT03718364 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Registry of patients with atrial fibrillation undergoing catheter-based ablation of atrial fibrillation (pulmonary vein isolation) to determine long-term success rates of catheter-based ablation of atrial fibrillation (pulmonary vein isolation) and to evaluate factors associated with long-term success of catheter-based ablation of atrial fibrillation (pulmonary vein isolation).

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * patients undergoing catheter-based ablation of atrial fibrillation (pulmonary vein isolation) Exclusion Criteria: * Patients not able or willing to participate in this study
💊

What it tests

  • catheter-based ablation of atrial fibrillation (pulmonary vein isolation)
📍

Where

2 sites
Cardiology/Electrophysiology, University Hospital Basel
Basel, Switzerland
University Hospital Bern
Bern, Switzerland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy